206 related articles for article (PubMed ID: 28577731)
1. Thrombotic microangiopathies and antineoplastic agents.
Grangé S; Coppo P;
Nephrol Ther; 2017 Apr; 13 Suppl 1():S109-S113. PubMed ID: 28577731
[TBL] [Abstract][Full Text] [Related]
2. [Secondary thrombotic microangiopathies].
Coppo P;
Rev Med Interne; 2017 Nov; 38(11):731-736. PubMed ID: 28890263
[TBL] [Abstract][Full Text] [Related]
3. Antineoplastic agents and thrombotic microangiopathy.
Garcia G; Atallah JP
J Oncol Pharm Pract; 2017 Mar; 23(2):135-142. PubMed ID: 26854265
[TBL] [Abstract][Full Text] [Related]
4. Anti-VEGF-related thrombotic microangiopathy in a child presenting with nephrotic syndrome.
Yılmaz S; Özçakar ZB; Taktak A; Kiremitçi S; Ensari A; Dinçaslan H; Yalçınkaya F
Pediatr Nephrol; 2016 Jun; 31(6):1029-32. PubMed ID: 26928310
[TBL] [Abstract][Full Text] [Related]
5. Thrombotic Microangiopathy in a Patient Treated With Gemcitabine.
Nanjappa S; Singh V; Uttamchandani S; Pabbathi S
Cancer Control; 2017 Jan; 24(1):54-56. PubMed ID: 28178713
[TBL] [Abstract][Full Text] [Related]
6. Thrombotic microangiopathy, cancer, and cancer drugs.
Izzedine H; Perazella MA
Am J Kidney Dis; 2015 Nov; 66(5):857-68. PubMed ID: 25943718
[TBL] [Abstract][Full Text] [Related]
7. An overview of thrombotic complications of old and new anticancer drugs.
Levi M; Sivapalaratnam S
Thromb Res; 2020 Jul; 191 Suppl 1():S17-S21. PubMed ID: 32736772
[TBL] [Abstract][Full Text] [Related]
8. Thrombotic microangiopathy syndromes.
Zakarija A
Cancer Treat Res; 2009; 148():115-36. PubMed ID: 19377922
[No Abstract] [Full Text] [Related]
9. Gemcitabine-related thrombotic microangiopathy: a single-centre retrospective series.
Leal F; Macedo LT; Carvalheira JB
J Chemother; 2014 Jun; 26(3):169-72. PubMed ID: 24091354
[TBL] [Abstract][Full Text] [Related]
10. Bevacizumab-associated thrombotic microangiopathy treated with eculizumab: A case series and systematic review of the literature.
Hilburg R; Geara AS; Qiu MK; Palmer MB; Chiang EY; Burger RA; Hogan JJ
Clin Nephrol; 2021 Jul; 96(1):51-59. PubMed ID: 33896447
[TBL] [Abstract][Full Text] [Related]
11. Influenza-induced thrombotic microangiopathy in a patient with cancer on proteasome inhibitor: a diagnostic dilemma.
Hamad CD; Hoelscher ZC; Tchakarov A; Kala J
CEN Case Rep; 2022 Aug; 11(3):321-327. PubMed ID: 34997535
[TBL] [Abstract][Full Text] [Related]
12. Sunitinib-induced thrombotic microangiopathy.
Noronha V; Punatar S; Joshi A; Desphande RV; Prabhash K
J Cancer Res Ther; 2016; 12(1):6-11. PubMed ID: 27072203
[TBL] [Abstract][Full Text] [Related]
13. [Thrombotic microangiopathy and cancer].
Kheder El-Fekih R; Deltombe C; Izzedine H
Nephrol Ther; 2017 Nov; 13(6):439-447. PubMed ID: 28774729
[TBL] [Abstract][Full Text] [Related]
14. Thrombotic microangiopathy associated with gemcitabine use: Presentation and outcome in a national French retrospective cohort.
Daviet F; Rouby F; Poullin P; Moussi-Francès J; Sallée M; Burtey S; Mancini J; Duffaud F; Sabatier R; Pourroy B; Grandvuillemin A; Grange S; Frémeaux-Bacchi V; Coppo P; Micallef J; Jourde-Chiche N
Br J Clin Pharmacol; 2019 Feb; 85(2):403-412. PubMed ID: 30394581
[TBL] [Abstract][Full Text] [Related]
15. Biology of anti-angiogenic therapy-induced thrombotic microangiopathy.
Eremina V; Quaggin SE
Semin Nephrol; 2010 Nov; 30(6):582-90. PubMed ID: 21146123
[TBL] [Abstract][Full Text] [Related]
16. Frequency and characteristics of chemotherapy-associated thrombotic microangiopathy: Analysis from a large pharmacovigilance database.
Klomjit N; Evans R; Le TK; Wells SL; Ortega J; Green-Lingren O; Mazepa M; Sise ME; Jhaveri KD; Gupta S
Am J Hematol; 2023 Dec; 98(12):E369-E372. PubMed ID: 37740927
[TBL] [Abstract][Full Text] [Related]
17. C5 inhibition allows continued antineoplastic therapy in cancer- and chemotherapy-associated thrombotic microangiopathy.
Shah H; Chen H; Pan XZ; Metjian A; Brodsky RA; Braunstein EM; Chaturvedi S
Blood Adv; 2022 Dec; 6(23):6071-6074. PubMed ID: 35914225
[No Abstract] [Full Text] [Related]
18. Sunitinib-associated thrombotic microangiopathy: a significant risk.
Buckley FD; Preston G; Meiklejohn DJ; Adamson D
Clin Oncol (R Coll Radiol); 2014 Aug; 26(8):515. PubMed ID: 24746506
[No Abstract] [Full Text] [Related]
19. Drug-associated thrombotic microangiopathies.
Kreuter J; Winters JL
Semin Thromb Hemost; 2012 Nov; 38(8):839-44. PubMed ID: 23037985
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological spectrum of kidney diseases in cancer patients treated with vascular endothelial growth factor inhibitors: a report of 5 cases and review of literature.
Usui J; Glezerman IG; Salvatore SP; Chandran CB; Flombaum CD; Seshan SV
Hum Pathol; 2014 Sep; 45(9):1918-27. PubMed ID: 25087655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]